Brought to you by 
Bock signs exclusive Dynabac mark. agreement with Lilly.
13 Jul 1999
Executive Summary
Bock Pharmacal (women's health and respiratory care) announced an exclusive US marketing agreement with Eli Lilly to distribute and promote Dynabac (dirithromycin tablets), Lilly's advanced macrolide antibiotic, for an undisclosed amount.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Bock signs exclusive Dynabac mark. agreement with Lilly.
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice